Vaccine-associated measles in a patient treated with natalizumab: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Vaccine-associated measles in a patient treated with natalizumab: a case report ; volume:20 ; number:1 ; day:14 ; month:10 ; year:2020 ; pages:1-4 ; date:12.2020
BMC infectious diseases ; 20, Heft 1 (14.10.2020), 1-4, 12.2020
- Urheber
-
Miauton, Alix
Tan, Rainer
Pantazou, Vasiliki
Du Pasquier, Renaud
Genton, Blaise
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-020-05475-9
- URN
-
urn:nbn:de:101:1-2020112913303291582469
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Miauton, Alix
- Tan, Rainer
- Pantazou, Vasiliki
- Du Pasquier, Renaud
- Genton, Blaise
- SpringerLink (Online service)
Ähnliche Objekte (12)
Local public health response to vaccine-associated measles: case report
Necrotizing fasciitis following measles vaccine administration: a case report
Resurgence of Measles in Europe: A Systematic Review on Parental Attitudes and Beliefs of Measles Vaccine
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Measles-Associated CNS Complications: A Review
COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Ein Peptidkonjugatvakzin gegen Masern : = A peptide-conjugate vaccine against measles
Measles virus as vaccine platform against highly pathogenic emerging viruses
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus
Is early measles vaccination associated with stronger survival benefits than later measles vaccination?
Local public health response to vaccine-associated measles: case report
Necrotizing fasciitis following measles vaccine administration: a case report
Resurgence of Measles in Europe: A Systematic Review on Parental Attitudes and Beliefs of Measles Vaccine
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Measles-Associated CNS Complications: A Review
COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Ein Peptidkonjugatvakzin gegen Masern : = A peptide-conjugate vaccine against measles
Measles virus as vaccine platform against highly pathogenic emerging viruses
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus
Is early measles vaccination associated with stronger survival benefits than later measles vaccination?
Local public health response to vaccine-associated measles: case report
Necrotizing fasciitis following measles vaccine administration: a case report
Resurgence of Measles in Europe: A Systematic Review on Parental Attitudes and Beliefs of Measles Vaccine
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Measles-Associated CNS Complications: A Review
COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Ein Peptidkonjugatvakzin gegen Masern : = A peptide-conjugate vaccine against measles
Measles virus as vaccine platform against highly pathogenic emerging viruses
Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus